Community/Retail

The novel intravenous immune globulin (IVIG) product is indicated for individuals with primary humoral immunodeficiency disease (PIDD), which includes X-linked and congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiency.

Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut, discusses recent key trials involving non-metastatic castrate-resistant prostate cancer.

Mary Koslap‐Petraco, DNP, PNPPC‐BC, CPNP, FAANP, Stony Brook University School of Nursing, discusses the difference between active and passive immunizations, and how they work to prevent disease. This video was filmed at the 2019 National Association of Pediatric Nurse Practitioners (NAP NAP) annual meeting in New Orleans.

Bernard Marini, PharmD, BCOP, an Inpatient Hematology Specialist at the University of Michigan, discusses the selection of therapies for patients with acute myeloid leukemia, during the Hematology/Oncology Pharmacy Association's 2019 annual meeting in Fort Worth, Texas.

Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses the benefits of pharmacist services and a personal success story. This video was filmed at the American Society of Consultant Pharmacists' 2019 Forum in Washington, DC.

Amber Draper, PharmD, BCOP, clinical pharmacist, Winship Cancer Institute in Georgia discusses educating patients about lifestyle and dietary factors that increase risk of colon cancer. This video was filmed at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, Texas.